Identifying the optimal treatment strategy in patients with resectable non-cardia gastric cancer.
Pranay S AjayRaja Kumaran RajamanickamKevin RheeRachel NeMoyerSubir GoyalJeffery M SwitchenkoYong LinSalma K JabbourDarren R CarpizoTimothy J KennedyMihir M ShahPublished in: Surgical endoscopy (2023)
In patients with resectable non-cardia gastric cancer, both perioperative chemotherapy and postoperative chemoradiation therapy were associated with improved survival when compared to postoperative chemotherapy. No difference was noted between perioperative chemotherapy and postoperative chemoradiation therapy. These results were maintained in the optimally treated cohort.